Psyllid ID: psy17158


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680------
MPRSEDDFDPGSKYHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL
cccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHcccccccHHHHHHHHHHHHHHHcccccccccccHHHcccccccccccccHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHccccccHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHcccccccccccccccccccccHHHHHccccHHHHHHHHHHHHHHcccccccHHHHHcccccccccccccccccEEEcccccccEEEEcccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccHHHHHHHcccccccccccHHHHHHHHHHHcccccccHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHccccccccccccccccccccccccccccc
ccEEcccccHHHcHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHcccHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccEEccccHHHHHHHHcccccccccccccHHHccccccHHHHHHHHHHHcccccccHHHHHHHHHcccccccccHHHHcHHHHHHHHHHHHHccccccccccccEcccccccHHHHHHHcccccccccccHHHHHHccccHHHHHHHHHHHHHHcccccccHHHHHHcEccccccHHHHHHHHHHHHHHHcccEEEccccEccEcccccEccccHHHHHHHHcccHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccEEccccccccccccHHHHHHHcccccccccccHHHHHHccccHHHHHHHHHHHHHHcccccccHHHHHHcEcccccccccccccEEEEccccccEEEEccccccHHHHHHHHHHHHHHHHHHHcccccHHHccccHHHHHHHHHHHHHHHHHcHHHHHHccccccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHcEEccccEEcccccHHHcHHHHcccccH
mprseddfdpgskyhipnnvEYLRYFVSYISQFQFHKALCteagqfdpknplktplhqyykDAGDSwialynqphfkETIEKLWTDIKPLYLELHAYVRRKLLAkygpevvfekepipahLLVHKALCteagqfdpknplktplhqcdiygskkAGNLFKKMLSlgaskpwpeALEVLTgqknldagpmlqyfDPLYKWLKEenrktgtfvgwekgrngnmwaQSWSNiyditqpypdkqepdiTKELQRQGYTVLKMFKKAEDFFLSLNMSkmttdfwensvfvrpkdrdiYSSVLSDMQKLFATaklcpynasasndtkcnldfdptvinimatsrdpKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVrlshykdagdswialynqphfkETIEKLWTDIKPLYVELHAYVRRKLLAkygpevvfekepipahllgnmWAQSWSniyditqpypdiqepditkELQRQNYTVLKMFKKAEDFFLSLNMSkmttdfwensvfvrpkdrdivchgsawdfhdgktyRIKLCALVGEDDLTTIHHEMghieydmmysqqlpfyqtspnpgfheavGDTIVLSVKTHKHLKRIGllkedfkddpesTINELFKFGlerltfppfgyltdlwrwsvfngsipedqYETAWWKLREeyqgvqppmprseddfdpgskyhipnnveyl
mprseddfdpgskyhipnNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGtfvgwekgrngnMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMTtdfwensvfvrpKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGsawdfhdgktYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGllkedfkddpeSTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYqgvqppmprseddfdpgskyhipnnveyl
MPRSEDDFDPGSKYHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL
*************YHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPY*********KELQRQGYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEY*****************************
MPRSEDDFDPGSKYHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKML*L*****WPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMT***********PKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL
*********PGSKYHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL
MPRSEDDFDPGSKYHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MPRSEDDFDPGSKYHIPNNVEYLRYFVSYISQFQFHKALCTEAGQFDPKNPLKTPLHQYYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYLELHAYVRRKLLAKYGPEVVFEKEPIPAHLLVHKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKNLDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query686 2.2.26 [Sep-21-2011]
P09470 1312 Angiotensin-converting en yes N/A 0.793 0.414 0.386 1e-124
Q10751 1193 Angiotensin-converting en yes N/A 0.798 0.459 0.414 1e-124
Q9GLN7 1304 Angiotensin-converting en yes N/A 0.793 0.417 0.386 1e-121
P12821 1306 Angiotensin-converting en yes N/A 0.793 0.416 0.386 1e-120
P47820 1313 Angiotensin-converting en yes N/A 0.778 0.406 0.386 1e-120
P12822 1310 Angiotensin-converting en yes N/A 0.793 0.415 0.376 1e-114
Q10714 615 Angiotensin-converting en yes N/A 0.562 0.627 0.466 1e-109
Q50JE5 1314 Angiotensin-converting en N/A N/A 0.602 0.314 0.427 1e-106
Q6Q4G4 616 Angiotensin-converting en N/A N/A 0.712 0.793 0.415 1e-106
Q10715 611 Angiotensin-converting en N/A N/A 0.562 0.631 0.459 1e-105
>sp|P09470|ACE_MOUSE Angiotensin-converting enzyme OS=Mus musculus GN=Ace PE=1 SV=3 Back     alignment and function desciption
 Score =  444 bits (1143), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 234/605 (38%), Positives = 348/605 (57%), Gaps = 61/605 (10%)

Query: 124  HKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKN 183
            H+ALC EAG        + PLHQCDIY S +AG   K++L  G S+PW E L+ L G   
Sbjct: 546  HQALCKEAGH-------QGPLHQCDIYQSAQAGAKLKQVLQAGCSRPWQEVLKDLVGSDA 598

Query: 184  LDAGPMLQYFDPLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIY--DITQPYPDKQE 241
            LDA  +L+YF P+ +WL+E+N++ G  +GW +    N W     + Y   I     + + 
Sbjct: 599  LDAKALLEYFQPVSQWLEEQNQRNGEVLGWPE----NQWRPPLPDNYPEGIDLETDEAKA 654

Query: 242  PDITKELQRQGYTVLKMFKKAE---DFFLSLNMSKM-----------------------T 275
                +E  R    +L  + +A    +  +++  SK+                        
Sbjct: 655  DRFVEEYDRTAQVLLNEYAEANWQYNTNITIEGSKILLEKSTEVSNHTLKYGTRAKTFDV 714

Query: 276  TDFWENSV-------------FVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKC 322
            ++F  +S+              + PK+ + Y+ +L DM+  ++ + +C  N +       
Sbjct: 715  SNFQNSSIKRIIKKLQNLDRAVLPPKELEEYNQILLDMETTYSLSNICYTNGTC------ 768

Query: 323  NLDFDPTVINIMATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAG 382
             +  +P + N+MATSR  +EL + W+ +R+K G+ +   + KYV+  N+  +L+ Y DAG
Sbjct: 769  -MPLEPDLTNMMATSRKYEELLWAWKSWRDKVGRAILPFFPKYVEFSNKIAKLNGYTDAG 827

Query: 383  DSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGN 442
            DSW +LY   + ++ +EKL+ +++PLY+ LHAYVRR L   YG E +    PIPAHLLGN
Sbjct: 828  DSWRSLYESDNLEQDLEKLYQELQPLYLNLHAYVRRSLHRHYGSEYINLDGPIPAHLLGN 887

Query: 443  MWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWE 502
            MWAQ+WSNIYD+  P+P     D T+ + +Q +T  ++FK+A++FF SL +  +  +FW 
Sbjct: 888  MWAQTWSNIYDLVAPFPSAPNIDATEAMIKQGWTPRRIFKEADNFFTSLGLLPVPPEFWN 947

Query: 503  NSVFVRPKD-RDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQ 561
             S+  +P D R++VCH SAWDF++GK +RIK C  V  +DL   HHEMGHI+Y M Y   
Sbjct: 948  KSMLEKPTDGREVVCHPSAWDFYNGKDFRIKQCTSVNMEDLVIAHHEMGHIQYFMQYKDL 1007

Query: 562  LPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLT 621
               ++   NPGFHEA+GD + LSV T KHL  + LL  +     E  IN L K  L+++ 
Sbjct: 1008 PVTFREGANPGFHEAIGDIMALSVSTPKHLYSLNLLSTE-GSGYEYDINFLMKMALDKIA 1066

Query: 622  FPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPN 681
            F PF YL D WRW VF+GSI ++ Y   WW LR +YQG+ PP+PRS+ DFDPGSK+H+P 
Sbjct: 1067 FIPFSYLIDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRSQGDFDPGSKFHVPA 1126

Query: 682  NVEYL 686
            NV Y+
Sbjct: 1127 NVPYV 1131




Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. This GPIase activity seems to be crucial for the egg-binding ability of the sperm.
Mus musculus (taxid: 10090)
EC: 3EC: .EC: 4EC: .EC: 1EC: 5EC: .EC: 1
>sp|Q10751|ACE_CHICK Angiotensin-converting enzyme (Fragment) OS=Gallus gallus GN=ACE PE=2 SV=1 Back     alignment and function description
>sp|Q9GLN7|ACE_PANTR Angiotensin-converting enzyme OS=Pan troglodytes GN=ACE PE=3 SV=1 Back     alignment and function description
>sp|P12821|ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 Back     alignment and function description
>sp|P47820|ACE_RAT Angiotensin-converting enzyme OS=Rattus norvegicus GN=Ace PE=2 SV=1 Back     alignment and function description
>sp|P12822|ACE_RABIT Angiotensin-converting enzyme OS=Oryctolagus cuniculus GN=ACE PE=1 SV=3 Back     alignment and function description
>sp|Q10714|ACE_DROME Angiotensin-converting enzyme OS=Drosophila melanogaster GN=Ance PE=1 SV=3 Back     alignment and function description
>sp|Q50JE5|ACE_MESAU Angiotensin-converting enzyme OS=Mesocricetus auratus GN=Ace PE=2 SV=1 Back     alignment and function description
>sp|Q6Q4G4|ACE_THETS Angiotensin-converting enzyme OS=Theromyzon tessulatum GN=ACE PE=2 SV=1 Back     alignment and function description
>sp|Q10715|ACE_HAEIX Angiotensin-converting enzyme OS=Haematobia irritans exigua GN=ACE PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query686
405971772 3545 Angiotensin-converting enzyme [Crassostr 0.797 0.154 0.429 1e-132
183986763 1284 angiotensin I converting enzyme 1 precur 0.779 0.416 0.395 1e-129
312375626 1952 hypothetical protein AND_13921 [Anophele 0.806 0.283 0.404 1e-128
326672223 1324 PREDICTED: angiotensin-converting enzyme 0.779 0.404 0.395 1e-128
395532965 1447 PREDICTED: angiotensin-converting enzyme 0.793 0.375 0.396 1e-127
327275269 1286 PREDICTED: angiotensin-converting enzyme 0.798 0.426 0.409 1e-126
331284213 1306 angiotensin I converting enzyme (peptidy 0.793 0.416 0.404 1e-126
403303843 1339 PREDICTED: angiotensin-converting enzyme 0.798 0.409 0.396 1e-126
449408 1306 angiotensin-converting enzyme 0.793 0.416 0.404 1e-126
402900709 1307 PREDICTED: angiotensin-converting enzyme 0.795 0.417 0.388 1e-125
>gi|405971772|gb|EKC36585.1| Angiotensin-converting enzyme [Crassostrea gigas] Back     alignment and taxonomy information
 Score =  479 bits (1233), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 255/594 (42%), Positives = 365/594 (61%), Gaps = 47/594 (7%)

Query: 124  HKALCTEAGQFDPKNPLKTPLHQCDIYGSKKAGNLFKKMLSLGASKPWPEALEVLTGQKN 183
            HKALC EAGQ         PL+QCDIY SK AG     ML LG+S+PW  A+E LTGQ+ 
Sbjct: 2226 HKALCEEAGQ-------TGPLYQCDIYQSKAAGKKLGDMLKLGSSQPWQHAMEKLTGQRK 2278

Query: 184  LDAGPMLQYFDPLYKWLKEENRKTG--------TFVGWEKGRNGNMWAQSWSNIYDITQP 235
            +D GP+++YF PL +WLK +N+           +F+          W +  + I  I + 
Sbjct: 2279 MDVGPLIEYFSPLLEWLKVQNQNESGGWMEECPSFLNKVDMETAKQWLKKNNEISQIERS 2338

Query: 236  YPDKQE----PDITKE-LQRQGYTVLKMFK-------KAEDFFLSLNMSKMT-------- 275
               + E     +IT E  +R+    L++ K       +A      LN+ K T        
Sbjct: 2339 KEGEVEWAYATNITDENSKREVEARLELAKYKKRSAKEASYLLRVLNIPKSTLMGRELYK 2398

Query: 276  -TDFWENSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIM 334
             ++   +++  + K R + + + SD++ ++A A++C      SNDT C L  +P +  IM
Sbjct: 2399 VSNIGTSALSDKSKLRKL-NGLQSDIEGIYAKAQVC-----VSNDT-C-LSLEPDISRIM 2450

Query: 335  ATSRDPKELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSH--YKDAGDSWIALYNQP 392
            ++SR+  EL+  W+ +R+ +GK M+ KYA++V++ NEG++  +  + D G  W + Y  P
Sbjct: 2451 SSSRNYTELSMIWKGWRDASGKKMKDKYAEFVKLSNEGIQELNMGFNDTGAYWRSAYETP 2510

Query: 393  HFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIY 452
             F+E +++L   +KPLY ELH YVR++L  +YG E+      IPAHLLGNMWAQ W+NIY
Sbjct: 2511 TFQEDLKQLLEQLKPLYQELHTYVRKQLRKQYGTELFPVSGQIPAHLLGNMWAQQWNNIY 2570

Query: 453  DITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDR 512
            D+  PY +  + DIT  L+ +NYT L+MF+ AE+FF SL +  M   FW  S+ V+P+ R
Sbjct: 2571 DLVIPYKNKAKIDITPVLKEKNYTALQMFRTAEEFFKSLGLKPMPETFWNKSMIVKPEGR 2630

Query: 513  DIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPG 572
            D+VCH SAWDF++ K +RIK+C  V  +DL TIHHEMGHI+Y + Y      ++   NPG
Sbjct: 2631 DVVCHASAWDFYNQKDFRIKMCTDVTMEDLITIHHEMGHIQYYLQYKDLPVAFRRGANPG 2690

Query: 573  FHEAVGDTIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLW 632
            FHEA+GDT+ LSV T KHL +IG LK +  +D ES +N L K  LE++ F PFGYL D W
Sbjct: 2691 FHEAIGDTMALSVSTPKHLHKIGFLK-NLTNDKESDLNFLMKMALEKIAFLPFGYLIDQW 2749

Query: 633  RWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL 686
            RWSVF+G  P+D+Y   WW+LR +YQG+  PMPR+EDDFDPG+KYHIP+N  Y+
Sbjct: 2750 RWSVFSGETPKDRYNQKWWELRCKYQGITSPMPRTEDDFDPGAKYHIPSNTPYI 2803




Source: Crassostrea gigas

Species: Crassostrea gigas

Genus: Crassostrea

Family: Ostreidae

Order: Ostreoida

Class: Bivalvia

Phylum: Mollusca

Superkingdom: Eukaryota

>gi|183986763|ref|NP_001116882.1| angiotensin I converting enzyme 1 precursor [Xenopus (Silurana) tropicalis] gi|166796450|gb|AAI59327.1| ace protein [Xenopus (Silurana) tropicalis] Back     alignment and taxonomy information
>gi|312375626|gb|EFR22959.1| hypothetical protein AND_13921 [Anopheles darlingi] Back     alignment and taxonomy information
>gi|326672223|ref|XP_694336.5| PREDICTED: angiotensin-converting enzyme [Danio rerio] Back     alignment and taxonomy information
>gi|395532965|ref|XP_003768534.1| PREDICTED: angiotensin-converting enzyme-like [Sarcophilus harrisii] Back     alignment and taxonomy information
>gi|327275269|ref|XP_003222396.1| PREDICTED: angiotensin-converting enzyme-like [Anolis carolinensis] Back     alignment and taxonomy information
>gi|331284213|ref|NP_001193597.1| angiotensin I converting enzyme (peptidyl-dipeptidase A) 3 precursor [Bos taurus] Back     alignment and taxonomy information
>gi|403303843|ref|XP_003942529.1| PREDICTED: angiotensin-converting enzyme [Saimiri boliviensis boliviensis] Back     alignment and taxonomy information
>gi|449408|prf||1919242A angiotensin-converting enzyme Back     alignment and taxonomy information
>gi|402900709|ref|XP_003913311.1| PREDICTED: angiotensin-converting enzyme-like [Papio anubis] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query686
ZFIN|ZDB-GENE-030131-1826 1324 ace "angiotensin I converting 0.657 0.340 0.432 1.3e-143
UNIPROTKB|F1NNH3 1193 ACE "Angiotensin-converting en 0.655 0.377 0.444 1.7e-143
UNIPROTKB|F1NYM0 1297 ACE "Angiotensin-converting en 0.655 0.346 0.444 1.7e-143
UNIPROTKB|Q10751 1193 ACE "Angiotensin-converting en 0.655 0.377 0.442 5e-142
UNIPROTKB|P12821 1306 ACE "Angiotensin-converting en 0.561 0.294 0.464 1.9e-140
UNIPROTKB|K7GRU7 1310 ACE "Uncharacterized protein" 0.568 0.297 0.458 3.1e-140
UNIPROTKB|F1RRW5 1309 ACE "Uncharacterized protein" 0.568 0.297 0.458 3.1e-140
MGI|MGI:87874 1312 Ace "angiotensin I converting 0.569 0.298 0.460 3.9e-138
RGD|2493 1313 Ace "angiotensin I converting 0.569 0.297 0.460 1.7e-137
UNIPROTKB|F1PCV3 1314 ACE "Uncharacterized protein" 0.567 0.296 0.448 5e-136
ZFIN|ZDB-GENE-030131-1826 ace "angiotensin I converting enzyme (peptidyl-dipeptidase A) 1" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
 Score = 1050 (374.7 bits), Expect = 1.3e-143, Sum P(3) = 1.3e-143
 Identities = 202/467 (43%), Positives = 290/467 (62%)

Query:   225 SWSNIYDITQPYPDKQEPDITKELQRQGYTV---LKMFKKAEDFFLSLNMSKMTTDFWE- 280
             SW+   DIT+ + D     + K L+   +T    L+  K     F   ++ ++ +   + 
Sbjct:   699 SWTYNTDITEAHKDNM---LQKNLEMANHTKIYGLEARKYDTSDFQDESVKRILSKLSDL 755

Query:   281 NSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDP 340
                 +  +D   Y+++L+ M+ L++ A +C      SN   C L  DP +  IMA SRD 
Sbjct:   756 ERAALSAEDLVEYNNLLASMETLYSVATVCK---DKSN---C-LPLDPDLNKIMAESRDY 808

Query:   341 KELAYYWQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEK 400
              EL + WQ +RN +G+ +R  Y +YV++ N   + + + D G  W +LY  P F++ +E 
Sbjct:   809 DELLFAWQGWRNASGREIRDSYKRYVELANSAAKSNGHTDNGAFWRSLYETPTFEQDLEA 868

Query:   401 LWTDIKPLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPD 460
             LW D++PLY+ +HAYVRR L  KYGPE +  K PIPAHLLGNMWAQ+WS I D+  PYPD
Sbjct:   869 LWKDLEPLYLSVHAYVRRALYKKYGPERINLKGPIPAHLLGNMWAQTWSGIMDLVNPYPD 928

Query:   461 IQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKD-RDIVCHGS 519
               + D T  +  Q +T  +MF++++ FF SL +  M  +FW  S+  +P D R++VCH S
Sbjct:   929 ATQVDATPAMIAQGWTPKRMFEESDRFFTSLGLLPMPPEFWNKSMLEKPTDGREVVCHAS 988

Query:   520 AWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGD 579
             AWDF++ K +RIK C +V  DDL T+HHEMGH++Y + Y  Q   ++   NPGFHEA+GD
Sbjct:   989 AWDFYNRKDFRIKQCTVVTMDDLITVHHEMGHVQYFLQYKDQPISFRDGANPGFHEAIGD 1048

Query:   580 TIVLSVKTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNG 639
              + LSV T KHL+ IGLL +  +D+ ESTIN L    L+++ F PFGYL D WRW VF+G
Sbjct:  1049 VLALSVATPKHLQSIGLL-DKVEDNAESTINFLMSIALDKIAFLPFGYLMDQWRWKVFDG 1107

Query:   640 SIPEDQYETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL 686
              I   +Y   WW LR +YQG+ PP+PR+E DFDPG+K+HIP NV Y+
Sbjct:  1108 RISSSEYNKEWWNLRMKYQGLCPPVPRTEKDFDPGAKFHIPANVPYI 1154


GO:0008237 "metallopeptidase activity" evidence=IEA
GO:0008241 "peptidyl-dipeptidase activity" evidence=IEA
GO:0006508 "proteolysis" evidence=IEA
GO:0016020 "membrane" evidence=IEA
UNIPROTKB|F1NNH3 ACE "Angiotensin-converting enzyme" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1NYM0 ACE "Angiotensin-converting enzyme" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|Q10751 ACE "Angiotensin-converting enzyme" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|P12821 ACE "Angiotensin-converting enzyme" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|K7GRU7 ACE "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|F1RRW5 ACE "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
MGI|MGI:87874 Ace "angiotensin I converting enzyme (peptidyl-dipeptidase A) 1" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|2493 Ace "angiotensin I converting enzyme (peptidyl-dipeptidase A) 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|F1PCV3 ACE "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
3rd Layer3.4.15.1LOW CONFIDENCE prediction!
3rd Layer3.4.15LOW CONFIDENCE prediction!

Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query686
cd06461562 cd06461, M2_ACE, Peptidase family M2 Angiotensin c 0.0
pfam01401 595 pfam01401, Peptidase_M2, Angiotensin-converting en 1e-145
cd06461562 cd06461, M2_ACE, Peptidase family M2 Angiotensin c 5e-36
cd06461562 cd06461, M2_ACE, Peptidase family M2 Angiotensin c 3e-35
pfam01401595 pfam01401, Peptidase_M2, Angiotensin-converting en 2e-25
cd06461562 cd06461, M2_ACE, Peptidase family M2 Angiotensin c 4e-23
cd06461562 cd06461, M2_ACE, Peptidase family M2 Angiotensin c 1e-22
pfam01401595 pfam01401, Peptidase_M2, Angiotensin-converting en 2e-18
pfam01401595 pfam01401, Peptidase_M2, Angiotensin-converting en 2e-16
pfam01401595 pfam01401, Peptidase_M2, Angiotensin-converting en 7e-15
cd09594125 cd09594, GluZincin, Peptidase Gluzincin family (th 3e-06
>gnl|CDD|188999 cd06461, M2_ACE, Peptidase family M2 Angiotensin converting enzyme (ACE) Back     alignment and domain information
 Score =  626 bits (1617), Expect = 0.0
 Identities = 211/400 (52%), Positives = 273/400 (68%), Gaps = 6/400 (1%)

Query: 287 PKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYY 346
           P   +  + +LS+M+ +++TAK+CPY+        C L  +P +  IMATSRD  EL + 
Sbjct: 83  PDKLEELNELLSEMETIYSTAKVCPYD-----GPGCCLSLEPDLEEIMATSRDYDELLWA 137

Query: 347 WQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIK 406
           W+ +R+  G  MR  Y +YV++ NE  RL+ + DAG+ W + Y    F+E +++LW  +K
Sbjct: 138 WEGWRDAVGPPMRPLYERYVELANEAARLNGFADAGEYWRSEYEMDDFEEDVDRLWEQVK 197

Query: 407 PLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDI 466
           PLY +LHAYVRRKL  KYG +VV    PIPAHLLGNMWAQSWSNIYD+ +PYP     D+
Sbjct: 198 PLYEQLHAYVRRKLREKYGDDVVSLDGPIPAHLLGNMWAQSWSNIYDLVKPYPGKPSIDV 257

Query: 467 TKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKDRDIVCHGSAWDFHDG 526
           T  + +Q YT LKMFK AE+FF SL +  M   FWE S+F +P DRD+VCH SAWDF++ 
Sbjct: 258 TDAMVKQGYTALKMFKTAEEFFTSLGLPPMPPSFWEKSMFEKPTDRDVVCHASAWDFYNR 317

Query: 527 KTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVK 586
           K +RIK+C  V  +D  T+HHEMGHI+Y + Y  Q   ++   NPGFHEAVGDTI LSV 
Sbjct: 318 KDFRIKMCTEVNMEDFITVHHEMGHIQYYLQYKDQPVLFRDGANPGFHEAVGDTIALSVS 377

Query: 587 THKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQY 646
           T KHLK+IGLL     DD E+ IN L K  L+++ F PFG L D WRW VF+G I  D Y
Sbjct: 378 TPKHLKKIGLLDSV-VDDEEADINFLLKMALDKIAFLPFGLLVDKWRWDVFSGEITPDNY 436

Query: 647 ETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL 686
             AWW+LRE+YQGV+PP+PRSE DFDPG+KYHIP N  Y+
Sbjct: 437 NKAWWELREKYQGVKPPVPRSETDFDPGAKYHIPANTPYI 476


Peptidase family M2 Angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension. Length = 562

>gnl|CDD|201774 pfam01401, Peptidase_M2, Angiotensin-converting enzyme Back     alignment and domain information
>gnl|CDD|188999 cd06461, M2_ACE, Peptidase family M2 Angiotensin converting enzyme (ACE) Back     alignment and domain information
>gnl|CDD|188999 cd06461, M2_ACE, Peptidase family M2 Angiotensin converting enzyme (ACE) Back     alignment and domain information
>gnl|CDD|201774 pfam01401, Peptidase_M2, Angiotensin-converting enzyme Back     alignment and domain information
>gnl|CDD|188999 cd06461, M2_ACE, Peptidase family M2 Angiotensin converting enzyme (ACE) Back     alignment and domain information
>gnl|CDD|188999 cd06461, M2_ACE, Peptidase family M2 Angiotensin converting enzyme (ACE) Back     alignment and domain information
>gnl|CDD|201774 pfam01401, Peptidase_M2, Angiotensin-converting enzyme Back     alignment and domain information
>gnl|CDD|201774 pfam01401, Peptidase_M2, Angiotensin-converting enzyme Back     alignment and domain information
>gnl|CDD|201774 pfam01401, Peptidase_M2, Angiotensin-converting enzyme Back     alignment and domain information
>gnl|CDD|189001 cd09594, GluZincin, Peptidase Gluzincin family (thermolysin-like proteinases, TLPs) includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins) Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 686
PF01401 595 Peptidase_M2: Angiotensin-converting enzyme This P 100.0
KOG3690|consensus 646 100.0
cd06461477 M2_ACE Peptidase family M2 Angiotensin converting 100.0
PF01401595 Peptidase_M2: Angiotensin-converting enzyme This P 100.0
KOG3690|consensus646 100.0
cd06461477 M2_ACE Peptidase family M2 Angiotensin converting 100.0
cd06258365 Peptidase_M3_like The peptidase M3-like family, al 99.95
cd06459427 M3B_Oligoendopeptidase_F Peptidase family M3B Olig 99.92
TIGR02289549 M3_not_pepF oligoendopeptidase, M3 family. This fa 99.92
COG1164598 Oligoendopeptidase F [Amino acid transport and met 99.77
TIGR00181591 pepF oligoendopeptidase F. This family represents 99.75
TIGR02290587 M3_fam_3 oligoendopeptidase, pepF/M3 family. The M 99.68
PF01432458 Peptidase_M3: Peptidase family M3 This Prosite mot 99.51
cd06460396 M32_Taq Peptidase family M32 is a subclass of meta 99.51
cd06455472 M3A_TOP Peptidase M3 Thimet oligopeptidase (TOP; P 99.33
PRK10911680 oligopeptidase A; Provisional 99.32
PRK10280681 dipeptidyl carboxypeptidase II; Provisional 99.09
cd06457458 M3A_MIP Peptidase M3 mitochondrial intermediate pe 98.99
PF02074494 Peptidase_M32: Carboxypeptidase Taq (M32) metallop 98.9
cd06456422 M3A_DCP_Oligopeptidase_A Peptidase family M3 dipep 98.75
COG2317497 Zn-dependent carboxypeptidase [Amino acid transpor 98.7
KOG2089|consensus718 98.66
cd06258365 Peptidase_M3_like The peptidase M3-like family, al 98.36
COG0339683 Dcp Zn-dependent oligopeptidases [Amino acid trans 98.29
KOG2090|consensus704 97.91
cd06459427 M3B_Oligoendopeptidase_F Peptidase family M3B Olig 89.98
TIGR02289549 M3_not_pepF oligoendopeptidase, M3 family. This fa 89.12
>PF01401 Peptidase_M2: Angiotensin-converting enzyme This Prosite motif covers only the active site Back     alignment and domain information
Probab=100.00  E-value=2.3e-157  Score=1326.92  Aligned_cols=473  Identities=49%  Similarity=0.909  Sum_probs=421.6

Q ss_pred             HHHHHHHHHHhhhCCcccccCCCCCCccccccccccCCCCCCCCCCchhHHHHHHHhhhHHHHHHHHHhhhccc----hh
Q psy17158        195 PLYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLS----LN  270 (686)
Q Consensus       195 PL~~WL~~~N~k~~~~~GW~~~~~~~~~~A~W~y~Tnit~~n~~~~~~~~e~~~~~~~f~~~~~~~~a~~F~~~----~~  270 (686)
                      =+.+||++.|.+....+.=.       +.|+|+|+||||++|.+   ++++++++.++|. ++.+++|++|+++    ++
T Consensus        15 eA~~FL~~yn~ea~~v~~~~-------a~A~W~y~TNITdeN~~---~~~ea~~~~a~F~-k~~~~~AkkFd~~~~~d~~   83 (595)
T PF01401_consen   15 EAKAFLEEYNREAEQVYYQS-------AEAQWNYNTNITDENQQ---LMAEASLEYAKFQ-KEYAKEAKKFDWTKFKDDT   83 (595)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH-------HHHHHHHHTS-SHHHHH---HHHHHHHHHHHHH-HHHHHHHTTSHGGGGSSHH
T ss_pred             HHHHHHHHHHHHHHHHHHHH-------HhhhhHhhcCCChHHHH---HHHHHHHHHHHHH-HHHHHHHHhcCcccCCCHH
Confidence            36789999998877763332       58999999999999999   9999999999999 9999999999986    77


Q ss_pred             HhhHHhhhcc-ccCCCChHhHHHHHHHHHHHHHhhhcceeccCCCCCCCCCCccCCChhhHHHHHhcCCCHHHHHHHHHH
Q psy17158        271 MSKMTTDFWE-NSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQE  349 (686)
Q Consensus       271 ~kRqL~~L~~-g~a~L~~e~~~el~~l~s~m~~iYstakvC~~~~~~~~~g~c~l~LepdL~~Ima~SrD~~eLk~aW~a  349 (686)
                      +||||++|+. |+++|++++++++++|+++|+++||++|||..+      ++| ++|+|||++||++|||++||+++|++
T Consensus        84 lkRql~~L~~lG~AaL~~~k~~el~~i~s~M~~iYst~kvC~~~------~~c-l~LePdl~~ima~Srd~~eL~~~W~~  156 (595)
T PF01401_consen   84 LKRQLKKLSKLGPAALPPEKLEELNKILSEMESIYSTAKVCPYD------GKC-LSLEPDLEEIMATSRDYDELLYAWEG  156 (595)
T ss_dssp             HHHHHHHHTS-GGGGSTHHHHHHHHHHHHHHHHHHHH-EEEESS------SEE-EETTTHHHHHHHH---HHHHHHHHHH
T ss_pred             HHHHHHHHhhcccccCCHHHHHHHHHHHHHHHHHhccccccCCC------Ccc-ccchhhHHHHHhccCCHHHHHHHHHH
Confidence            9999999999 999999999999999999999999999999875      789 99999999999999999999999999


Q ss_pred             HHHHHhhHHHHHHHHHHHHHHHHHHHcCCCChHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCcc
Q psy17158        350 FRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVV  429 (686)
Q Consensus       350 Wr~~vg~~~r~~y~~~V~L~N~aAr~nGf~d~ge~Wr~~Ye~~~~~~~~e~lw~qIkPLY~qLHayVR~kL~~~YG~~~v  429 (686)
                      ||+++|++||+.|.+||+|.|+||+.|||+|+|+|||+.||+++|++++++||++|+|||+|||||||++|+++||+++|
T Consensus       157 Wr~~vg~~~r~~y~~~V~L~N~aA~~nG~~d~g~~Wr~~ye~~~~~~~~~~lw~~i~PLY~~LHayVR~~L~~~Yg~~~v  236 (595)
T PF01401_consen  157 WRDAVGPPMRPLYERYVELSNEAARLNGFKDTGEYWRSSYEMPNFEQELERLWQQIKPLYKQLHAYVRRKLREKYGDDVV  236 (595)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTSSSHHHHHHGGG-CTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTS
T ss_pred             HHHHhhhHHHHHHHHHHHHHHHHHHHcCCCCHHHHHHHHhccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccccccccccCCCCCCCChhHHHHHccCcHHHHHHHHHHHHHhcCCCCCChHHHhccccccC
Q psy17158        430 FEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRP  509 (686)
Q Consensus       430 ~~~gpIPAHLLGnmwaq~W~niyd~~~P~P~~~~~Dvt~~l~~q~yt~~~Mfk~Ae~FF~SLGL~~mp~~FW~~Sm~~kp  509 (686)
                      +.+||||||||||||||+|+|||+++.|||+.+.+|||++|++||||+++||++||+||+||||++||++||++|||+||
T Consensus       237 ~~~gpIPAHLLGnmwaq~W~ni~~~~~P~p~~~~~dvt~~l~~q~~t~~~mf~~ae~ff~SlGl~~mp~~FW~~S~~~kp  316 (595)
T PF01401_consen  237 PPDGPIPAHLLGNMWAQSWSNIYDLVLPYPDKPSLDVTEELVKQGYTAKKMFKTAEEFFTSLGLPPMPPTFWEKSMFEKP  316 (595)
T ss_dssp             -TTS-EEGGGSSSTTSS-GGGGHHHH-STTTS--S-THHHHHHTT--HHHHHHHHHHHHHHTTS----HHHHHHSB-S--
T ss_pred             CCCCCccHHHHHHHHHHHHhhhhccccCCCCCCCCCcHHHHHHccccHHHHHHHHHHHHHhCCCCcCCHHHHHHHHhcCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CC-CCcccccccccCCCCCceeEEecCcCCcchHHHHHHHHHHHHHHHHhcCCCCCCCCCCCchhHhHHHHHHHHhhcCh
Q psy17158        510 KD-RDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTH  588 (686)
Q Consensus       510 ~d-r~v~ChasAwDf~~~~D~RIkmCt~vt~~Df~tvHHEmGHi~Y~~~Y~~qP~~fR~gANpgFhEAIgd~iaLSv~TP  588 (686)
                      .| |+|+|||||||||+++||||||||++|++||.|+||||||||||++|++||++||+||||||||||||+|+|||+||
T Consensus       317 ~d~r~~~Chasawdf~~~~d~Rik~Ct~v~~~df~t~hhemghi~Y~~~y~~qp~~fr~gan~gfhEAigd~ials~~tp  396 (595)
T PF01401_consen  317 TDGRDVVCHASAWDFYNGDDFRIKMCTEVTMEDFLTAHHEMGHIQYYMQYKDQPVLFREGANPGFHEAIGDTIALSVSTP  396 (595)
T ss_dssp             SSSS----S-EEEEESSSSEEEEE----SSHHHHHHHHHHHHHHHHHHHTTTS-GGGSS-SSHHHHHHHHHHHHHHHTSH
T ss_pred             CCCCCCCcCcchhhccCCCccceeecccCCHHHHHHHHHHHHHHHHHHHHhhCChhhhcCCCchHHHHHHHHHHHHcCCH
Confidence            98 99999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHhCCCCCCCCCChhhhHHHHHHHhhhhhccCchhhhhhhhhHhhcCCCCChhhHHHHHHHHHHHhCcccCCCCCCC
Q psy17158        589 KHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSE  668 (686)
Q Consensus       589 ~hL~~iGLl~~~~~~~~e~~IN~Ll~~AL~kI~fLPf~~~~D~WRw~VF~g~i~~~~~N~~WW~Lr~kYQGI~pPv~R~e  668 (686)
                      +||+++|||++. .++.+.+||+||++||+||+||||||++|+|||+||+|+|++++||++||+||++||||+|||+|+|
T Consensus       397 ~hL~~~gLl~~~-~~~~~~~in~L~~~AL~ki~~lPf~~~~d~wRw~vf~g~i~~~~~n~~wW~lr~~yqGi~pP~~r~~  475 (595)
T PF01401_consen  397 KHLKRIGLLDNV-TDDEESDINFLLKQALDKIAFLPFGYLMDKWRWDVFSGSIPPDQYNEAWWELREKYQGIVPPVERSE  475 (595)
T ss_dssp             HHHHHTTSSSTT-TTSHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHTTSS-CCGHHHHHHHHHHHHHSEE-SS-EET
T ss_pred             HHHHHcCCCCCC-CcchHHHHHHHHHHhhhHHHhccHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHHcCCccCCCCCCc
Confidence            999999999987 7788999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccCcccccCCCCCC
Q psy17158        669 DDFDPGSKYHIPNNVEYL  686 (686)
Q Consensus       669 ~dFDpgAKyHI~~n~pYi  686 (686)
                      +||||||||||++|+|||
T Consensus       476 ~~fD~~ak~hi~~~~py~  493 (595)
T PF01401_consen  476 SDFDPGAKYHIPANTPYI  493 (595)
T ss_dssp             TS-GGGGSHHHHTT--SH
T ss_pred             ccCCcchhhhhccccccH
Confidence            999999999999999996



; InterPro: IPR001548 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold: Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, N-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; N, asparagine; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. In the case of the asparagine endopeptidases, the nucleophile is asparagine and all are self-processing endopeptidases. In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding. Metalloproteases are the most diverse of the four main types of protease, with more than 50 families identified to date. In these enzymes, a divalent cation, usually zinc, activates the water molecule. The metal ion is held in place by amino acid ligands, usually three in number. The known metal ligands are His, Glu, Asp or Lys and at least one other residue is required for catalysis, which may play an electrophillic role. Of the known metalloproteases, around half contain an HEXXH motif, which has been shown in crystallographic studies to form part of the metal-binding site []. The HEXXH motif is relatively common, but can be more stringently defined for metalloproteases as 'abXHEbbHbc', where 'a' is most often valine or threonine and forms part of the S1' subsite in thermolysin and neprilysin, 'b' is an uncharged residue, and 'c' a hydrophobic residue. Proline is never found in this site, possibly because it would break the helical structure adopted by this motif in metalloproteases []. This group of metallopeptidases belong to the MEROPS peptidase family M2 (clan MA(E)). The protein fold of the peptidase domain for members of this family resembles that of thermolysin, the type example for clan MA. The catalytic residues and zinc ligands have been identified, the zinc ion being ligated to two His residues within the motif HEXXH, showing that the enzyme belongs to the E sub-group of metalloproteases []. Pepetidyl-dipeptidase A (angiotensin-converting enzyme) is a mammalian enzyme responsible for cleavage of dipeptides from the C-termini of proteins, notably converting angiotensin I to angiotensin II []. The enzyme exists in two differentially transcribed forms, the most common of which is from lung endothelium; this contains two homologous domains that have arisen by gene duplication []. The testis-specific form contains only the C-terminal domain, arising from a duplicated promoter region present in intron 12 of the gene []. Both enzymatic forms are membrane proteins that are anchored by means of a C-terminal transmembrane domain. Both domains of the endothelial enzyme are active, but have differing kinetic constants []. ]. A number of insect enzymes have been shown to be similar to peptidyl-dipeptidase A, these containing a single catalytic domain.; GO: 0008237 metallopeptidase activity, 0008241 peptidyl-dipeptidase activity, 0006508 proteolysis, 0016020 membrane; PDB: 2YDM_A 3BKL_A 2C6N_B 1UZE_A 3BKK_A 2C6F_B 2IUX_A 2IUL_A 2XYD_B 3NXQ_B ....

>KOG3690|consensus Back     alignment and domain information
>cd06461 M2_ACE Peptidase family M2 Angiotensin converting enzyme (ACE, EC 3 Back     alignment and domain information
>PF01401 Peptidase_M2: Angiotensin-converting enzyme This Prosite motif covers only the active site Back     alignment and domain information
>KOG3690|consensus Back     alignment and domain information
>cd06461 M2_ACE Peptidase family M2 Angiotensin converting enzyme (ACE, EC 3 Back     alignment and domain information
>cd06258 Peptidase_M3_like The peptidase M3-like family, also called neurolysin-like family, is part of the "zincins" metallopeptidases, and includes M3, M2 and M32 families of metallopeptidases Back     alignment and domain information
>cd06459 M3B_Oligoendopeptidase_F Peptidase family M3B Oligopeptidase F (PepF; Pz-peptidase B; EC 3 Back     alignment and domain information
>TIGR02289 M3_not_pepF oligoendopeptidase, M3 family Back     alignment and domain information
>COG1164 Oligoendopeptidase F [Amino acid transport and metabolism] Back     alignment and domain information
>TIGR00181 pepF oligoendopeptidase F Back     alignment and domain information
>TIGR02290 M3_fam_3 oligoendopeptidase, pepF/M3 family Back     alignment and domain information
>PF01432 Peptidase_M3: Peptidase family M3 This Prosite motif covers only the active site Back     alignment and domain information
>cd06460 M32_Taq Peptidase family M32 is a subclass of metallocarboxypeptidases which are distributed mainly in bacteria and archaea, and contain a HEXXH motif that coordinates a divalent cation such as Zn2+ or Co2+, so far only observed in the active site of neutral metallopeptidases but not in carboxypeptidases Back     alignment and domain information
>cd06455 M3A_TOP Peptidase M3 Thimet oligopeptidase (TOP; PZ-peptidase; endo-oligopeptidase A; endopeptidase 24 Back     alignment and domain information
>PRK10911 oligopeptidase A; Provisional Back     alignment and domain information
>PRK10280 dipeptidyl carboxypeptidase II; Provisional Back     alignment and domain information
>cd06457 M3A_MIP Peptidase M3 mitochondrial intermediate peptidase (MIP; EC 3 Back     alignment and domain information
>PF02074 Peptidase_M32: Carboxypeptidase Taq (M32) metallopeptidase; InterPro: IPR001333 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families Back     alignment and domain information
>cd06456 M3A_DCP_Oligopeptidase_A Peptidase family M3 dipeptidyl carboxypeptidase (DCP; Dcp II; peptidyl dipeptidase; EC 3 Back     alignment and domain information
>COG2317 Zn-dependent carboxypeptidase [Amino acid transport and metabolism] Back     alignment and domain information
>KOG2089|consensus Back     alignment and domain information
>cd06258 Peptidase_M3_like The peptidase M3-like family, also called neurolysin-like family, is part of the "zincins" metallopeptidases, and includes M3, M2 and M32 families of metallopeptidases Back     alignment and domain information
>COG0339 Dcp Zn-dependent oligopeptidases [Amino acid transport and metabolism] Back     alignment and domain information
>KOG2090|consensus Back     alignment and domain information
>cd06459 M3B_Oligoendopeptidase_F Peptidase family M3B Oligopeptidase F (PepF; Pz-peptidase B; EC 3 Back     alignment and domain information
>TIGR02289 M3_not_pepF oligoendopeptidase, M3 family Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query686
2x8y_A 598 Crystal Structure Of Ance Length = 598 1e-110
2x92_A 599 Crystal Structure Of Ance-Ramiprilat Complex Length 1e-110
1j36_A 607 Crystal Structure Of Drosophila Ance Length = 607 1e-110
2iux_A 591 Human Tace Mutant G1234 Length = 591 1e-109
2ydm_A 589 Structural Characterization Of Angiotensin-I Conver 1e-109
2xy9_A 585 Human Angiotensin Converting Enzyme In Complex With 1e-109
2oc2_A 591 Structure Of Testis Ace With Rxpa380 Length = 591 1e-109
1o8a_A 589 Crystal Structure Of Human Angiotensin Converting E 1e-109
3bkk_A 591 Tesis Ace Co-Crystal Structure With Ketone Ace Inhi 1e-108
2iul_A 591 Human Tace G13 Mutant Length = 591 1e-108
2c6n_A 612 Structure Of Human Somatic Angiontensin-I Convertin 1e-102
2xyd_A 610 Human Angiotenisn Converting Enzyme N-Domain In Com 1e-102
3nxq_A 629 Angiotensin Converting Enzyme N Domain Glycsoylatio 1e-102
3sck_A 603 Crystal Structure Of Spike Protein Receptor-Binding 9e-85
1r42_A 615 Native Human Angiotensin Converting Enzyme-related 1e-84
3d0g_A 597 Crystal Structure Of Spike Protein Receptor-Binding 1e-84
2ajf_A 597 Structure Of Sars Coronavirus Spike Receptor-Bindin 2e-84
3sci_A 603 Crystal Structure Of Spike Protein Receptor-Binding 2e-84
>pdb|2X8Y|A Chain A, Crystal Structure Of Ance Length = 598 Back     alignment and structure

Iteration: 1

Score = 395 bits (1016), Expect = e-110, Method: Compositional matrix adjust. Identities = 183/392 (46%), Positives = 263/392 (67%), Gaps = 6/392 (1%) Query: 296 VLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFRNKTG 355 LS M+ FA K+C Y S TKC+L DP + +++ SRD +ELAYYW+EF +K G Sbjct: 103 TLSAMESNFAKVKVCDYKDS----TKCDLALDPEIEEVISKSRDHEELAYYWREFYDKAG 158 Query: 356 KLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAY 415 +R ++ +YV++ + +L+++ ++W+ Y F++ +E ++ DI+PLY ++H Y Sbjct: 159 TAVRSQFERYVELNTKAAKLNNFTSGAEAWLDEYEDDTFEQQLEDIFADIRPLYQQIHGY 218 Query: 416 VRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNY 475 VR +L YG VV E PIP HLLGNMWAQ WS I DI P+P+ D++ E+++Q Y Sbjct: 219 VRFRLRKHYGDAVVSETGPIPMHLLGNMWAQQWSEIADIVSPFPEKPLVDVSAEMEKQGY 278 Query: 476 TVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKD-RDIVCHGSAWDFHDGKTYRIKLC 534 T LKMF+ +DFF S+N++K+ DFW+ S+ +P D RD+VCH SAWDF+ RIK C Sbjct: 279 TPLKMFQMGDDFFTSMNLTKLPQDFWDKSIIEKPTDGRDLVCHASAWDFYLTDDVRIKQC 338 Query: 535 ALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKHLKRI 594 V +D L T+HHE+GHI+Y + Y Q Y+T NPGFHEAVGD + LSV T KHL++I Sbjct: 339 TRVTQDQLFTVHHELGHIQYFLQYQHQPFVYRTGANPGFHEAVGDVLSLSVSTPKHLEKI 398 Query: 595 GLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLR 654 GLLK+ +DD E+ IN+LF L+++ F PF + D +RWS+F G + + + A+WKLR Sbjct: 399 GLLKDYVRDD-EARINQLFLTALDKIVFLPFAFTMDKYRWSLFRGEVDKANWNCAFWKLR 457 Query: 655 EEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL 686 +EY G++PP+ RSE DFD +KYHI +VEYL Sbjct: 458 DEYSGIEPPVVRSEKDFDAPAKYHISADVEYL 489
>pdb|2X92|A Chain A, Crystal Structure Of Ance-Ramiprilat Complex Length = 599 Back     alignment and structure
>pdb|1J36|A Chain A, Crystal Structure Of Drosophila Ance Length = 607 Back     alignment and structure
>pdb|2IUX|A Chain A, Human Tace Mutant G1234 Length = 591 Back     alignment and structure
>pdb|2YDM|A Chain A, Structural Characterization Of Angiotensin-I Converting Enzyme In Complex With A Selenium Analogue Of Captopril Length = 589 Back     alignment and structure
>pdb|2XY9|A Chain A, Human Angiotensin Converting Enzyme In Complex With Phosphinic Tripeptide Length = 585 Back     alignment and structure
>pdb|2OC2|A Chain A, Structure Of Testis Ace With Rxpa380 Length = 591 Back     alignment and structure
>pdb|1O8A|A Chain A, Crystal Structure Of Human Angiotensin Converting Enzyme (Native). Length = 589 Back     alignment and structure
>pdb|3BKK|A Chain A, Tesis Ace Co-Crystal Structure With Ketone Ace Inhibitor Kaf Length = 591 Back     alignment and structure
>pdb|2IUL|A Chain A, Human Tace G13 Mutant Length = 591 Back     alignment and structure
>pdb|2C6N|A Chain A, Structure Of Human Somatic Angiontensin-I Converting Enzyme N Domain With Lisinopril Length = 612 Back     alignment and structure
>pdb|2XYD|A Chain A, Human Angiotenisn Converting Enzyme N-Domain In Complex With Phosphinic Tripeptide Length = 610 Back     alignment and structure
>pdb|3NXQ|A Chain A, Angiotensin Converting Enzyme N Domain Glycsoylation Mutant (Ndom389) In Complex With Rxp407 Length = 629 Back     alignment and structure
>pdb|3SCK|A Chain A, Crystal Structure Of Spike Protein Receptor-Binding Domain From A Predicted Sars Coronavirus Civet Strain Complexed With Human-Civet Chimeric Receptor Ace2 Length = 603 Back     alignment and structure
>pdb|1R42|A Chain A, Native Human Angiotensin Converting Enzyme-related Carboxypeptidase (ace2) Length = 615 Back     alignment and structure
>pdb|3D0G|A Chain A, Crystal Structure Of Spike Protein Receptor-Binding Domain From The 2002-2003 Sars Coronavirus Human Strain Complexed With Human-Civet Chimeric Receptor Ace2 Length = 597 Back     alignment and structure
>pdb|2AJF|A Chain A, Structure Of Sars Coronavirus Spike Receptor-Binding Domain Complexed With Its Receptor Length = 597 Back     alignment and structure
>pdb|3SCI|A Chain A, Crystal Structure Of Spike Protein Receptor-Binding Domain From A Predicted Sars Coronavirus Human Strain Complexed With Human Receptor Ace2 Length = 603 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query686
2x96_A 598 Angiotensin converting enzyme; hydrolase, ACE inhi 1e-151
2x96_A598 Angiotensin converting enzyme; hydrolase, ACE inhi 9e-30
2x96_A598 Angiotensin converting enzyme; hydrolase, ACE inhi 4e-22
2x96_A598 Angiotensin converting enzyme; hydrolase, ACE inhi 5e-15
2x96_A598 Angiotensin converting enzyme; hydrolase, ACE inhi 2e-13
1uze_A 589 Angiotensin converting enzyme; metalloprotease, in 1e-147
1uze_A589 Angiotensin converting enzyme; metalloprotease, in 2e-26
1uze_A589 Angiotensin converting enzyme; metalloprotease, in 2e-20
1uze_A589 Angiotensin converting enzyme; metalloprotease, in 8e-15
1uze_A589 Angiotensin converting enzyme; metalloprotease, in 2e-11
3nxq_A 629 Angiotensin-converting enzyme; dicarboxy zinc meta 1e-146
3nxq_A629 Angiotensin-converting enzyme; dicarboxy zinc meta 4e-25
3nxq_A629 Angiotensin-converting enzyme; dicarboxy zinc meta 6e-19
3nxq_A629 Angiotensin-converting enzyme; dicarboxy zinc meta 1e-14
3nxq_A629 Angiotensin-converting enzyme; dicarboxy zinc meta 4e-11
1r42_A 615 Angiotensin I converting enzyme 2; zinc metallopep 1e-139
1r42_A615 Angiotensin I converting enzyme 2; zinc metallopep 7e-24
1r42_A615 Angiotensin I converting enzyme 2; zinc metallopep 2e-20
1r42_A615 Angiotensin I converting enzyme 2; zinc metallopep 1e-10
1r42_A615 Angiotensin I converting enzyme 2; zinc metallopep 1e-10
1ka2_A499 M32 carboxypeptidase; hexxh motif, M32 family, met 1e-11
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 4e-11
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-09
3dwc_A505 TCMCP-1, metallocarboxypeptidase; cowrin family of 2e-04
>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Length = 598 Back     alignment and structure
 Score =  450 bits (1157), Expect = e-151
 Identities = 182/401 (45%), Positives = 263/401 (65%), Gaps = 6/401 (1%)

Query: 287 PKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYY 346
             D       LS M+  FA  K+C Y     + TKC+L  DP +  +++ SRD +ELAYY
Sbjct: 94  EDDYAELLDTLSAMESNFAKVKVCDYK----DSTKCDLALDPEIEEVISKSRDHEELAYY 149

Query: 347 WQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIK 406
           W+EF +K G  +R ++ +YV++  +  +L+++    ++W+  Y    F++ +E ++ DI+
Sbjct: 150 WREFYDKAGTAVRSQFERYVELNTKAAKLNNFTSGAEAWLDEYEDDTFEQQLEDIFADIR 209

Query: 407 PLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDI 466
           PLY ++H YVR +L   YG  VV E  PIP HLLGNMWAQ WS I DI  P+P+    D+
Sbjct: 210 PLYQQIHGYVRFRLRKHYGDAVVSETGPIPMHLLGNMWAQQWSEIADIVSPFPEKPLVDV 269

Query: 467 TKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKD-RDIVCHGSAWDFHD 525
           + E+++Q YT LKMF+  +DFF S+N++K+  DFW+ S+  +P D RD+VCH SAWDF+ 
Sbjct: 270 SAEMEKQGYTPLKMFQMGDDFFTSMNLTKLPQDFWDKSIIEKPTDGRDLVCHASAWDFYL 329

Query: 526 GKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSV 585
               RIK C  V +D L T+HHE+GHI+Y + Y  Q   Y+T  NPGFHEAVGD + LSV
Sbjct: 330 TDDVRIKQCTRVTQDQLFTVHHELGHIQYFLQYQHQPFVYRTGANPGFHEAVGDVLSLSV 389

Query: 586 KTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQ 645
            T KHL++IGLL +D+  D E+ IN+LF   L+++ F PF +  D +RWS+F G + +  
Sbjct: 390 STPKHLEKIGLL-KDYVRDDEARINQLFLTALDKIVFLPFAFTMDKYRWSLFRGEVDKAN 448

Query: 646 YETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEYL 686
           +  A+WKLR+EY G++PP+ RSE DFD  +KYHI  +VEYL
Sbjct: 449 WNCAFWKLRDEYSGIEPPVVRSEKDFDAPAKYHISADVEYL 489


>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Length = 598 Back     alignment and structure
>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Length = 598 Back     alignment and structure
>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Length = 598 Back     alignment and structure
>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Length = 598 Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Length = 589 Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Length = 589 Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Length = 589 Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Length = 589 Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Length = 589 Back     alignment and structure
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Length = 629 Back     alignment and structure
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Length = 629 Back     alignment and structure
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Length = 629 Back     alignment and structure
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Length = 629 Back     alignment and structure
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Length = 629 Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Length = 615 Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Length = 615 Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Length = 615 Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Length = 615 Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Length = 615 Back     alignment and structure
>1ka2_A M32 carboxypeptidase; hexxh motif, M32 family, metallopeptidase; 2.20A {Pyrococcus furiosus} SCOP: d.92.1.5 PDB: 1k9x_A 1ka4_A Length = 499 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3dwc_A TCMCP-1, metallocarboxypeptidase; cowrin family of metallocarboxypept carboxypeptidase, hydrolase; 2.10A {Trypanosoma cruzi} Length = 505 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query686
3nxq_A 629 Angiotensin-converting enzyme; dicarboxy zinc meta 100.0
2x96_A 598 Angiotensin converting enzyme; hydrolase, ACE inhi 100.0
1uze_A 589 Angiotensin converting enzyme; metalloprotease, in 100.0
1r42_A 615 Angiotensin I converting enzyme 2; zinc metallopep 100.0
3nxq_A629 Angiotensin-converting enzyme; dicarboxy zinc meta 100.0
3ahn_A564 Oligopeptidase, PZ peptidase A; hydrolase, hydrola 99.97
2x96_A598 Angiotensin converting enzyme; hydrolase, ACE inhi 99.97
1uze_A589 Angiotensin converting enzyme; metalloprotease, in 99.94
1r42_A615 Angiotensin I converting enzyme 2; zinc metallopep 99.94
3ce2_A618 Putative peptidase; structural genomics, unknown f 99.92
2qr4_A587 Peptidase M3B, oligoendopeptidase F; structural ge 99.9
3sks_A567 Putative oligoendopeptidase F; structural genomics 99.85
2o3e_A678 Neurolysin; thermolysin-like domain, substrate-bin 99.63
2o36_A674 ThiMet oligopeptidase; thermolysin-like domain, su 99.61
3hoa_A509 Thermostable carboxypeptidase 1; proline-rich loop 99.58
1y79_1680 Peptidyl-dipeptidase DCP; hinge bending, carboxype 99.56
1ka2_A499 M32 carboxypeptidase; hexxh motif, M32 family, met 99.56
3hq2_A501 Bacillus subtilis M32 carboxypeptidase; hydrolase, 99.41
3dwc_A505 TCMCP-1, metallocarboxypeptidase; cowrin family of 99.19
3hq2_A501 Bacillus subtilis M32 carboxypeptidase; hydrolase, 96.37
3ce2_A618 Putative peptidase; structural genomics, unknown f 95.8
2qr4_A587 Peptidase M3B, oligoendopeptidase F; structural ge 95.79
3ahn_A564 Oligopeptidase, PZ peptidase A; hydrolase, hydrola 95.51
1ka2_A499 M32 carboxypeptidase; hexxh motif, M32 family, met 92.85
3hoa_A509 Thermostable carboxypeptidase 1; proline-rich loop 91.32
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Back     alignment and structure
Probab=100.00  E-value=8.1e-143  Score=1212.23  Aligned_cols=474  Identities=39%  Similarity=0.777  Sum_probs=456.0

Q ss_pred             HHHHHHHHHhhhCCcccccCCCCCCccccccccccCCCCCCCCCCchhHHHHHHHhhhHHHHHHHHHhhhc---cc----
Q psy17158        196 LYKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFF---LS----  268 (686)
Q Consensus       196 L~~WL~~~N~k~~~~~GW~~~~~~~~~~A~W~y~Tnit~~n~~~~~~~~e~~~~~~~f~~~~~~~~a~~F~---~~----  268 (686)
                      +.+||.+.|++....+.-       .+.|+|+|+||||++|.+   ++++++++.++|. ++.+++|++|+   +.    
T Consensus        17 a~~fl~~~~~~~~~~~~~-------~~~a~W~y~tnit~~~~~---~~~~~~~~~~~~~-~~~~~~a~~f~~~~~~~~~d   85 (629)
T 3nxq_A           17 AQLFAQSYQSSAEQVLFQ-------SVAASWAHDTNITAENAR---RQEEAALLSQEFA-EAWGQKAKELYEPIWQQFTD   85 (629)
T ss_dssp             HHHHHHHHHHHHHHHHHH-------HHHHHHHHHTSCCHHHHH---HHHHHHHHHHHHH-HHHHHHHHHHHTTTGGGCSC
T ss_pred             HHHHHHHHHHHHHHHHHH-------HHhhhhhhhccCcHHHHH---HHHHHHHHHHHHH-HHHHHHHHhcccccccccCC
Confidence            678999999887765322       258999999999999999   9999999999999 99999999997   43    


Q ss_pred             hhHhhHHhhhcc-ccCCCChHhHHHHHHHHHHHHHhhhcceeccCCCCCCCCCCccCCChhhHHHHHhcCCCHHHHHHHH
Q psy17158        269 LNMSKMTTDFWE-NSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYW  347 (686)
Q Consensus       269 ~~~kRqL~~L~~-g~a~L~~e~~~el~~l~s~m~~iYstakvC~~~~~~~~~g~c~l~LepdL~~Ima~SrD~~eLk~aW  347 (686)
                      +++||||++|+. |+++|++++++++++|+++|++|||+++||.++    .+++| ++|+|||.+||++|+|+++|++||
T Consensus        86 ~~~~R~l~~l~~~g~~~l~~~~~~e~n~l~s~m~~iy~~akvc~~~----g~~~c-l~L~pdL~~im~~SrD~~er~~aW  160 (629)
T 3nxq_A           86 PQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQ----KTATC-WSLDPDLTNILASSRSYAMLLFAW  160 (629)
T ss_dssp             HHHHHHHHHHTCCGGGGSCHHHHHHHHHHHHHHHHHHHHCEEEC-------CCCE-EETTTHHHHHHHHCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhhCccCCCHHHHHHHHHHHHHHHHHhhceEEecCC----CCccc-ccchhHHHHHHhhCCCHHHHHHHH
Confidence            999999999999 999999999999999999999999999999864    23579 999999999999999999999999


Q ss_pred             HHHHHHHhhHHHHHHHHHHHHHHHHHHHcCCCChHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCC
Q psy17158        348 QEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPE  427 (686)
Q Consensus       348 ~aWr~~vg~~~r~~y~~~V~L~N~aAr~nGf~d~ge~Wr~~Ye~~~~~~~~e~lw~qIkPLY~qLHayVR~kL~~~YG~~  427 (686)
                      ++||+++|++++++|.+||+|+|++||.|||+|+|+|||+.||++++.+++++||++|+|||++||+|||++|+++||++
T Consensus       161 ~~wr~~~g~~l~~~y~~~V~LrneaAk~~Gf~d~~e~wR~~Ye~~~~~~~~e~l~~~i~PLy~~Lha~vR~~L~~~Yg~~  240 (629)
T 3nxq_A          161 EGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDR  240 (629)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCSSHHHHHHHTTCCTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCHHHHHHHhcCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccccccccccCCCCCCCChhHHHHHccCcHHHHHHHHHHHHHhcCCCCCChHHHhccccc
Q psy17158        428 VVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFV  507 (686)
Q Consensus       428 ~v~~~gpIPAHLLGnmwaq~W~niyd~~~P~P~~~~~Dvt~~l~~q~yt~~~Mfk~Ae~FF~SLGL~~mp~~FW~~Sm~~  507 (686)
                      +|+.+||||||||||||||+|+||||+++|||+++.+|||++|++||||+++||+.|++||+||||++||++||++||++
T Consensus       241 ~i~~~g~iPaHLlgnmw~q~W~~~yd~~~Pf~~~~~~dvt~~m~~qg~t~~~mf~~ae~ff~sLGl~~~~~~Fw~~sl~~  320 (629)
T 3nxq_A          241 YINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLE  320 (629)
T ss_dssp             TCCTTSCEETTSSSSTTSCCCGGGHHHHCSCTTSCCCCCHHHHHHHTCCHHHHHHHHHHHHHHTTCCCCCHHHHHHCBCS
T ss_pred             ccCCCCCcChhhccchhhhchhhhcccccCCCCCCcccchHHHHHcCCCHHHHHHHHHHHHHHcCCCcCChHHHHHHHHc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCC-CCcccccccccCCCCCceeEEecCcCCcchHHHHHHHHHHHHHHHHhcCCCCCCCCCCCchhHhHHHHHHHHhhc
Q psy17158        508 RPKD-RDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVK  586 (686)
Q Consensus       508 kp~d-r~v~ChasAwDf~~~~D~RIkmCt~vt~~Df~tvHHEmGHi~Y~~~Y~~qP~~fR~gANpgFhEAIgd~iaLSv~  586 (686)
                      ||+| |+++|||||||||+.+||||||||++|++||.|+||||||||||++|++||++||+||||||||||||+||||++
T Consensus       321 kp~d~~~~~Chasawd~~~~~d~rIk~C~~~t~~D~~t~hHEmGH~qy~~~y~~~P~~~r~~anpgfhEAige~~slS~~  400 (629)
T 3nxq_A          321 KPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVS  400 (629)
T ss_dssp             CCSSSCCCCCSCEEEECSSSSCEEEECCCCSSHHHHHHHHHHHHHHHHHHHSTTSCGGGCSCSSHHHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCcCcchhhcccCcCceEEECCCCCHHHHHHHHHHHHHHHHHHHHhcCCccccCCCCchHHHHHHHHHHHHcC
Confidence            9999 999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHHhCCCCCCCCCChhhhHHHHHHHhhhhhccCchhhhhhhhhHhhcCCCCChhhHHHHHHHHHHHhCcccCCCCC
Q psy17158        587 THKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPR  666 (686)
Q Consensus       587 TP~hL~~iGLl~~~~~~~~e~~IN~Ll~~AL~kI~fLPf~~~~D~WRw~VF~g~i~~~~~N~~WW~Lr~kYQGI~pPv~R  666 (686)
                      ||+||+++|||+.. .++.+++||+||+|||++|+|||||++||+|||.||+|+++++++|+.||+|+++||||+||+.|
T Consensus       401 Tp~hL~~igLl~~~-~~~~e~~in~l~~~aL~~i~fLPf~~~vD~wrw~vf~g~it~~d~n~~WweL~~~Y~Gi~Pp~dr  479 (629)
T 3nxq_A          401 TPEHLHKIGLLDRV-TNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTR  479 (629)
T ss_dssp             SHHHHHHTTSSCCC-CCSHHHHHHHHHHHHHHHTTTHHHHHHHHHHHHHHHHTSSCGGGHHHHHHHHHHHHHCEECSSCC
T ss_pred             CHHHHHHcCCcccc-CCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999875 55567889999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccCcccccCCCCCC
Q psy17158        667 SEDDFDPGSKYHIPNNVEYL  686 (686)
Q Consensus       667 ~e~dFDpgAKyHI~~n~pYi  686 (686)
                      ++.+|||||||||++++|||
T Consensus       480 ~~~~fD~gak~Hi~~~~yYi  499 (629)
T 3nxq_A          480 NETHFDAGAKFHVPNVTPYI  499 (629)
T ss_dssp             CTTCCGGGGSTTTTTTCCCH
T ss_pred             CccccCccceEEEecCccHH
Confidence            99999999999999999996



>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Back     alignment and structure
>3nxq_A Angiotensin-converting enzyme; dicarboxy zinc metallopeptidase, hydrolase, hydrolase-hydrol inhibitor complex; HET: RX4 NAG FUC BMA P6G PG4; 1.99A {Homo sapiens} PDB: 2xyd_A* 2c6n_A* 2c6f_A* Back     alignment and structure
>3ahn_A Oligopeptidase, PZ peptidase A; hydrolase, hydrolase-hydrolase inhibitor complex; HET: 3A1; 1.80A {Geobacillus SP} PDB: 3ahm_A* 3aho_A* 2h1n_A 2h1j_A Back     alignment and structure
>2x96_A Angiotensin converting enzyme; hydrolase, ACE inhibitor, zinc metallopeptidase; HET: RX3 EPE NAG BMA MAN; 1.85A {Drosophila melanogaster} PDB: 2x8z_A* 2x90_A* 2x91_A* 2x8y_A* 2x97_A* 2xhm_A* 3zqz_A* 2x94_A* 2x92_A* 2x93_A* 2x95_A* 1j36_A* 1j37_A* 1j38_A Back     alignment and structure
>1uze_A Angiotensin converting enzyme; metalloprotease, inhibitor, enalaprilat, zinc dependant peptidase, anti-hypertensive drug; HET: EAL; 1.82A {Homo sapiens} SCOP: d.92.1.5 PDB: 1o8a_A* 1o86_A* 1uzf_A* 2oc2_A* 2ydm_A* 2iux_A* 2iul_A* 2xy9_A* 3bkk_A* 3bkl_A* 3l3n_A* Back     alignment and structure
>1r42_A Angiotensin I converting enzyme 2; zinc metallopeptidase domain, Na open conformation, chloride ION binding site; HET: NAG; 2.20A {Homo sapiens} SCOP: d.92.1.5 PDB: 1r4l_A* 3sci_A 3scj_A 2ajf_A* 3kbh_A* 3d0g_A* 3d0h_A* 3d0i_A* 3sck_A 3scl_A Back     alignment and structure
>3ce2_A Putative peptidase; structural genomics, unknown function, P protein structure initiative; 2.60A {Chlamydophila abortus} Back     alignment and structure
>2qr4_A Peptidase M3B, oligoendopeptidase F; structural genomics, PSI-2, protein ST initiative; 2.50A {Enterococcus faecium} Back     alignment and structure
>3sks_A Putative oligoendopeptidase F; structural genomics, center for structural genomics of infec diseases, csgid, protease, hydrolase; 2.05A {Bacillus anthracis} Back     alignment and structure
>2o3e_A Neurolysin; thermolysin-like domain, substrate-binding channel, hydrolase; 2.20A {Rattus norvegicus} PDB: 1i1i_P Back     alignment and structure
>2o36_A ThiMet oligopeptidase; thermolysin-like domain, substrate-binding channel, hydrolase; 1.95A {Homo sapiens} PDB: 1s4b_P Back     alignment and structure
>3hoa_A Thermostable carboxypeptidase 1; proline-rich loop, hydrolase; 2.10A {Thermus thermophilus HB27} SCOP: d.92.1.0 PDB: 1wgz_A Back     alignment and structure
>1y79_1 Peptidyl-dipeptidase DCP; hinge bending, carboxypeptidase, neurolysin, ACE, hydrolase; HET: TRP; 2.00A {Escherichia coli} Back     alignment and structure
>1ka2_A M32 carboxypeptidase; hexxh motif, M32 family, metallopeptidase; 2.20A {Pyrococcus furiosus} SCOP: d.92.1.5 PDB: 1k9x_A 1ka4_A Back     alignment and structure
>3hq2_A Bacillus subtilis M32 carboxypeptidase; hydrolase, metal-binding, metalloprotease, protease, zinc; 2.90A {Bacillus subtilis} SCOP: d.92.1.0 Back     alignment and structure
>3dwc_A TCMCP-1, metallocarboxypeptidase; cowrin family of metallocarboxypept carboxypeptidase, hydrolase; 2.10A {Trypanosoma cruzi} Back     alignment and structure
>3hq2_A Bacillus subtilis M32 carboxypeptidase; hydrolase, metal-binding, metalloprotease, protease, zinc; 2.90A {Bacillus subtilis} SCOP: d.92.1.0 Back     alignment and structure
>3ce2_A Putative peptidase; structural genomics, unknown function, P protein structure initiative; 2.60A {Chlamydophila abortus} Back     alignment and structure
>2qr4_A Peptidase M3B, oligoendopeptidase F; structural genomics, PSI-2, protein ST initiative; 2.50A {Enterococcus faecium} Back     alignment and structure
>3ahn_A Oligopeptidase, PZ peptidase A; hydrolase, hydrolase-hydrolase inhibitor complex; HET: 3A1; 1.80A {Geobacillus SP} PDB: 3ahm_A* 3aho_A* 2h1n_A 2h1j_A Back     alignment and structure
>1ka2_A M32 carboxypeptidase; hexxh motif, M32 family, metallopeptidase; 2.20A {Pyrococcus furiosus} SCOP: d.92.1.5 PDB: 1k9x_A 1ka4_A Back     alignment and structure
>3hoa_A Thermostable carboxypeptidase 1; proline-rich loop, hydrolase; 2.10A {Thermus thermophilus HB27} SCOP: d.92.1.0 PDB: 1wgz_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 686
d1j36a_ 598 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 1e-122
d1j36a_598 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 2e-31
d1j36a_598 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 3e-17
d1j36a_598 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 3e-15
d1j36a_598 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 6e-08
d1uzea_579 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 1e-100
d1uzea_579 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 4e-26
d1uzea_579 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 1e-13
d1uzea_579 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 2e-11
d1uzea_579 d.92.1.5 (A:) Angiotensin converting enzyme, ACE { 1e-07
d2ajfa1 597 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2e-97
d2ajfa1597 d.92.1.5 (A:19-615) Angiotensin converting enzyme 8e-25
d2ajfa1597 d.92.1.5 (A:19-615) Angiotensin converting enzyme 1e-13
d2ajfa1597 d.92.1.5 (A:19-615) Angiotensin converting enzyme 3e-11
d2ajfa1597 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2e-04
d1k9xa_497 d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Arc 1e-35
d1k9xa_497 d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Arc 3e-09
d1k9xa_497 d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Arc 3e-07
>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 598 Back     information, alignment and structure

class: Alpha and beta proteins (a+b)
fold: Zincin-like
superfamily: Metalloproteases ("zincins"), catalytic domain
family: Neurolysin-like
domain: Angiotensin converting enzyme, ACE
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
 Score =  374 bits (960), Expect = e-122
 Identities = 181/400 (45%), Positives = 261/400 (65%), Gaps = 6/400 (1%)

Query: 287 PKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYY 346
             D       LS M+  FA  K+C Y     + TKC+L  DP +  +++ SRD +ELAYY
Sbjct: 88  EDDYAELLDTLSAMESNFAKVKVCDYK----DSTKCDLALDPEIEEVISKSRDHEELAYY 143

Query: 347 WQEFRNKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIK 406
           W+EF +K G  +R ++ +YV++  +  +L+++    ++W+  Y    F++ +E ++ DI+
Sbjct: 144 WREFYDKAGTAVRSQFERYVELNTKAAKLNNFTSGAEAWLDEYEDDTFEQQLEDIFADIR 203

Query: 407 PLYVELHAYVRRKLLAKYGPEVVFEKEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDI 466
           PLY ++H YVR +L   YG  VV E  PIP HLLGNMWAQ WS I DI  P+P+    D+
Sbjct: 204 PLYQQIHGYVRFRLRKHYGDAVVSETGPIPMHLLGNMWAQQWSEIADIVSPFPEKPLVDV 263

Query: 467 TKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKD-RDIVCHGSAWDFHD 525
           + E+++Q YT LKMF+  +DFF S+N++K+  DFW+ S+  +P D RD+VCH SAWDF+ 
Sbjct: 264 SAEMEKQAYTPLKMFQMGDDFFTSMNLTKLPQDFWDKSIIEKPTDGRDLVCHASAWDFYL 323

Query: 526 GKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSV 585
               RIK C  V +D L T+HHE+GHI+Y + Y  Q   Y+T  NPGFHEAVGD + LSV
Sbjct: 324 IDDVRIKQCTRVTQDQLFTVHHELGHIQYFLQYQHQPFVYRTGANPGFHEAVGDVLSLSV 383

Query: 586 KTHKHLKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQ 645
            T KHL++IGLLK+    D E+ IN+LF   L+++ F PF +  D +RWS+F G + +  
Sbjct: 384 STPKHLEKIGLLKDYV-RDDEARINQLFLTALDKIVFLPFAFTMDKYRWSLFRGEVDKAN 442

Query: 646 YETAWWKLREEYQGVQPPMPRSEDDFDPGSKYHIPNNVEY 685
           +  A+WKLR+EY G++PP+ RSE DFD  +KYHI  +VEY
Sbjct: 443 WNCAFWKLRDEYSGIEPPVVRSEKDFDAPAKYHISADVEY 482


>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 598 Back     information, alignment and structure
>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 598 Back     information, alignment and structure
>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 598 Back     information, alignment and structure
>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 598 Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Length = 579 Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Length = 579 Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Length = 579 Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Length = 579 Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Length = 579 Back     information, alignment and structure
>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Length = 597 Back     information, alignment and structure
>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Length = 597 Back     information, alignment and structure
>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Length = 597 Back     information, alignment and structure
>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Length = 597 Back     information, alignment and structure
>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Length = 597 Back     information, alignment and structure
>d1k9xa_ d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Archaeon Pyrococcus furiosus [TaxId: 2261]} Length = 497 Back     information, alignment and structure
>d1k9xa_ d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Archaeon Pyrococcus furiosus [TaxId: 2261]} Length = 497 Back     information, alignment and structure
>d1k9xa_ d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Archaeon Pyrococcus furiosus [TaxId: 2261]} Length = 497 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query686
d1j36a_ 598 Angiotensin converting enzyme, ACE {Fruit fly (Dro 100.0
d2ajfa1 597 Angiotensin converting enzyme 2, ACE2 {Human (Homo 100.0
d1uzea_579 Angiotensin converting enzyme, ACE {Human (Homo sa 100.0
d1j36a_598 Angiotensin converting enzyme, ACE {Fruit fly (Dro 100.0
d2ajfa1597 Angiotensin converting enzyme 2, ACE2 {Human (Homo 99.94
d1uzea_579 Angiotensin converting enzyme, ACE {Human (Homo sa 99.94
d1k9xa_497 Thermostable carboxypeptidase 1 {Archaeon Pyrococc 99.92
d1s4bp_654 Neurolysin (endopeptidase 24.16, thimet oligopepti 99.21
d1i1ip_665 Neurolysin (endopeptidase 24.16, thimet oligopepti 99.15
d1k9xa_497 Thermostable carboxypeptidase 1 {Archaeon Pyrococc 98.31
>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
class: Alpha and beta proteins (a+b)
fold: Zincin-like
superfamily: Metalloproteases ("zincins"), catalytic domain
family: Neurolysin-like
domain: Angiotensin converting enzyme, ACE
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=100.00  E-value=2e-107  Score=921.08  Aligned_cols=474  Identities=40%  Similarity=0.780  Sum_probs=454.6

Q ss_pred             HHHHHHHHhhhCCcccccCCCCCCccccccccccCCCCCCCCCCchhHHHHHHHhhhHHHHHHHHHhhhccc----hhHh
Q psy17158        197 YKWLKEENRKTGTFVGWEKGRNGNMWAQSWSNIYDITQPYPDKQEPDITKELQRQGYTVLKMFKKAEDFFLS----LNMS  272 (686)
Q Consensus       197 ~~WL~~~N~k~~~~~GW~~~~~~~~~~A~W~y~Tnit~~n~~~~~~~~e~~~~~~~f~~~~~~~~a~~F~~~----~~~k  272 (686)
                      .+||++.|++.....-       ..+.|+|+|+||||++|.+   ++.+++.+++.|. .+.++++++|++.    +.+|
T Consensus         4 ~~fl~~~~~~~~~~~~-------~~s~A~w~y~tn~tdet~~---~~~e~~~~~a~~~-~e~~~~~~~f~~~~~~~~~~k   72 (598)
T d1j36a_           4 KEYLENLNKELAKRTN-------VETEAAWAYRSAITDENEK---KKNEISAELAKFM-KEVASDTTKFQWRSYQSEDLK   72 (598)
T ss_dssp             HHHHHHHHHHHHHHHH-------HHHHHHHHHTTSCCHHHHH---HHHHHHHHHHHHH-HHHHTGGGSSCGGGCSSTTHH
T ss_pred             HHHHHHHHHHHHHHHH-------HHHhhhhHHhccCCHHHHH---HHHHHHHHHHHHH-HHHHHHHHhcccccCCCHHHH
Confidence            6788888887666422       1248999999999999999   9999999999999 9999999999765    7899


Q ss_pred             hHHhhhcc-ccCCCChHhHHHHHHHHHHHHHhhhcceeccCCCCCCCCCCccCCChhhHHHHHhcCCCHHHHHHHHHHHH
Q psy17158        273 KMTTDFWE-NSVFVRPKDRDIYSSVLSDMQKLFATAKLCPYNASASNDTKCNLDFDPTVINIMATSRDPKELAYYWQEFR  351 (686)
Q Consensus       273 RqL~~L~~-g~a~L~~e~~~el~~l~s~m~~iYstakvC~~~~~~~~~g~c~l~LepdL~~Ima~SrD~~eLk~aW~aWr  351 (686)
                      |||+.|.. +..+|++++++++++++++|+++||+++||.++    ++..|.+.++|++.+||++|||+++++++|.+||
T Consensus        73 r~l~~l~~~~~~~l~~~~~~el~~l~~~~~~l~s~a~v~~~~----~~~~~~l~l~~~~~~i~~~srd~~el~~~w~~~~  148 (598)
T d1j36a_          73 RQFKALTKLGYAALPEDDYAELLDTLSAMESNFAKVKVCDYK----DSTKCDLALDPEIEEVISKSRDHEELAYYWREFY  148 (598)
T ss_dssp             HHHHHHHCCSGGGSCHHHHHHHHHHHHHHHHHHHTCEECBTT----BTTTCCEETTTHHHHHHHHCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCHHHHHHHHHHHHHHHHHhcceeeecCC----CCcccchhcchhHHHhhhccCCHHHHHHHHHHHH
Confidence            99999999 999999999999999999999999999999875    3345669999999999999999999999999999


Q ss_pred             HHHhhHHHHHHHHHHHHHHHHHHHcCCCChHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCccCC
Q psy17158        352 NKTGKLMRKKYAKYVQILNEGVRLSHYKDAGDSWIALYNQPHFKETIEKLWTDIKPLYVELHAYVRRKLLAKYGPEVVFE  431 (686)
Q Consensus       352 ~~vg~~~r~~y~~~V~L~N~aAr~nGf~d~ge~Wr~~Ye~~~~~~~~e~lw~qIkPLY~qLHayVR~kL~~~YG~~~v~~  431 (686)
                      +++|++++++|.++|+|+|++|+.|||+|+++|||+.|+++++.+.+++||.+|+|+|.+||+|||.+|+++||.+.++.
T Consensus       149 ~~~~~~~~~~~~~lv~lrn~~A~~lGf~n~~e~~r~~y~~~~~~~~~e~l~~~v~p~~~~l~~~~r~~l~~~yg~~~~~~  228 (598)
T d1j36a_         149 DKAGTAVRSQFERYVELNTKAAKLNNFTSGAEAWLDEYEDDTFEQQLEDIFADIRPLYQQIHGYVRFRLRKHYGDAVVSE  228 (598)
T ss_dssp             HHHTGGGHHHHHHHHHHHHHHHHHTTCSSHHHHHHHTTCCTTHHHHHHHHHHHHHHHHTTTHHHHHHHHHHHHCTTTSCT
T ss_pred             HHhhhhhhhhHHHHHHHHHHHHHHcCCCcHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhccCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccccccccccccccccccccCCCCCCCChhHHHHHccCcHHHHHHHHHHHHHhcCCCCCChHHHhccccccCCC
Q psy17158        432 KEPIPAHLLGNMWAQSWSNIYDITQPYPDIQEPDITKELQRQNYTVLKMFKKAEDFFLSLNMSKMTTDFWENSVFVRPKD  511 (686)
Q Consensus       432 ~gpIPAHLLGnmwaq~W~niyd~~~P~P~~~~~Dvt~~l~~q~yt~~~Mfk~Ae~FF~SLGL~~mp~~FW~~Sm~~kp~d  511 (686)
                      +|+||||||||||+|+|.++++++.|+|..+.+||+..|.+++++..+|+++|++||+|||+.+|+++||++|++.+|.+
T Consensus       229 ~~~i~a~llg~~~~~~w~~~~~~~~p~~~~~~~dv~~~l~~~~~~~~~m~~~a~~ff~sl~~~~l~d~~w~~s~~~~~~~  308 (598)
T d1j36a_         229 TGPIPMHLLGNMWAQQWSEIADIVSPFPEKPLVDVSAEMEKQAYTPLKMFQMGDDFFTSMNLTKLPQDFWDKSIIEKPTD  308 (598)
T ss_dssp             TSCEETTSSSSTTCSCCGGGHHHHCSCTTSCCCCTHHHHHHTTCCHHHHHHHHHHHHHTTTCCCCCHHHHHHCBCSCCSS
T ss_pred             ccccchhhhcchhhcccccccccccCCcCCCCCCHHHHHHHhCccHHHHHHHHHHHHHHhcccccchHHHhhhhcccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             -CCcccccccccCCCCCceeEEecCcCCcchHHHHHHHHHHHHHHHHhcCCCCCCCCCCCchhHhHHHHHHHHhhcChhH
Q psy17158        512 -RDIVCHGSAWDFHDGKTYRIKLCALVGEDDLTTIHHEMGHIEYDMMYSQQLPFYQTSPNPGFHEAVGDTIVLSVKTHKH  590 (686)
Q Consensus       512 -r~v~ChasAwDf~~~~D~RIkmCt~vt~~Df~tvHHEmGHi~Y~~~Y~~qP~~fR~gANpgFhEAIgd~iaLSv~TP~h  590 (686)
                       +++.|||+|||||+.+|+||+||+.+|++|+.|+||||||++|+++|++||++||+++||||||||||++++++.||+|
T Consensus       309 ~k~~~~~a~a~~~~~~~~p~I~~n~~~t~~dv~Tl~HE~GH~~h~~~~~~qp~~~~~~~~~~~~~~~~e~~sl~~~~~~~  388 (598)
T d1j36a_         309 GRDLVCHASAWDFYLIDDVRIKQCTRVTQDQLFTVHHELGHIQYFLQYQHQPFVYRTGANPGFHEAVGDVLSLSVSTPKH  388 (598)
T ss_dssp             SCCCCCSCEEEECSSSSCEEEECCCCSSHHHHHHHHHHHHHHHHHHHHTTSCGGGCSCSHHHHHHHHHHHHHHHHHSHHH
T ss_pred             CCCCCCCceeecCCCCCCCceecCCCCcHHHHHHHHHHHHHHHHHHHHccCCchhccCCCcchHHHHHHHHHHhhccHHH
Confidence             8999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCChhhhHHHHHHHhhhhhccCchhhhhhhhhHhhcCCCCChhhHHHHHHHHHHHhCcccCCCCCCCCC
Q psy17158        591 LKRIGLLKEDFKDDPESTINELFKFGLERLTFPPFGYLTDLWRWSVFNGSIPEDQYETAWWKLREEYQGVQPPMPRSEDD  670 (686)
Q Consensus       591 L~~iGLl~~~~~~~~e~~IN~Ll~~AL~kI~fLPf~~~~D~WRw~VF~g~i~~~~~N~~WW~Lr~kYQGI~pPv~R~e~d  670 (686)
                      |+++||++.. ..+.+.++|+||++||++|+||||++++|+|||.||+|+++++++|+.||+||++||||+||++|++++
T Consensus       389 l~~~~l~~~~-~~~~e~~~~~l~~~~l~~i~flp~~~~~d~~~~~v~~~~~~~~~~n~~w~~l~~~y~g~~~p~~~~~~~  467 (598)
T d1j36a_         389 LEKIGLLKDY-VRDDEARINQLFLTALDKIVFLPFAFTMDKYRWSLFRGEVDKANWNCAFWKLRDEYSGIEPPVVRSEKD  467 (598)
T ss_dssp             HHHTTSSSSC-CCCSTTTHHHHHHHHTTTTTHHHHHHHHHHHHHHHHTTTSCGGGHHHHHHHHHHHHHCEECSSCEETTC
T ss_pred             Hhhccccccc-cCchhhhHHHHHHHHHHHHHhhhHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHHhcCCCCCCCCChhh
Confidence            9999999875 567778999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccCcccccCCCCCC
Q psy17158        671 FDPGSKYHIPNNVEYL  686 (686)
Q Consensus       671 FDpgAKyHI~~n~pYi  686 (686)
                      |||||||||++|+|||
T Consensus       468 fd~~~~~Hi~~~~~Y~  483 (598)
T d1j36a_         468 FDAPAKYHISADVEYL  483 (598)
T ss_dssp             CCGGGSHHHHHTCCCH
T ss_pred             ccccccceeCCCccHH
Confidence            9999999999999995



>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1j36a_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d2ajfa1 d.92.1.5 (A:19-615) Angiotensin converting enzyme 2, ACE2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzea_ d.92.1.5 (A:) Angiotensin converting enzyme, ACE {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1k9xa_ d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Archaeon Pyrococcus furiosus [TaxId: 2261]} Back     information, alignment and structure
>d1s4bp_ d.92.1.5 (P:) Neurolysin (endopeptidase 24.16, thimet oligopeptidase) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1i1ip_ d.92.1.5 (P:) Neurolysin (endopeptidase 24.16, thimet oligopeptidase) {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1k9xa_ d.92.1.5 (A:) Thermostable carboxypeptidase 1 {Archaeon Pyrococcus furiosus [TaxId: 2261]} Back     information, alignment and structure